Both in Biotechnology
Scholar Rock Holding vs CRISPR Therapeutics AG
Over the past year SRRK returned +48.2% and CRSP returned −19.6%; their daily moves had a correlation of 0.28.
SRRK +48.2% CRSP −19.6%Growth of $1, one year, split-adjusted
| Metric | SRRK | CRSP |
|---|---|---|
| Price | $43.90 | $51.42 |
| Market cap | $5.35B | $4.97B |
| Today | −0.63% | −5.23% |
| 1 month | −4.9% | −7.3% |
| 6 months | −5.3% | −0.4% |
| Year to date | −0.3% | −1.9% |
| 1 year | +50.0% | −17.8% |
| Revenue growth (YoY) | — | +1041.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −895.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 371.3× |
| Net cash | $295.9M | $1.78B |
| Dividend yield | — | — |
| Volatility (60d) | 43.2% | 53.4% |
| Short % of float | 20.3% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).